BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 1578484)

  • 1. Side chain modified 5-deazafolate and 5-deazatetrahydrofolate analogues as mammalian folylpolyglutamate synthetase and glycinamide ribonucleotide formyltransferase inhibitors: synthesis and in vitro biological evaluation.
    Rosowsky A; Forsch RA; Reich VE; Freisheim JH; Moran RG
    J Med Chem; 1992 May; 35(9):1578-88. PubMed ID: 1578484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 5-deazafolate analogues with a rotationally restricted glutamate or ornithine side chain: synthesis and binding interaction with folylpolyglutamate synthetase.
    Rosowsky A; Forsch RA; Null A; Moran RG
    J Med Chem; 1999 Sep; 42(18):3510-9. PubMed ID: 10479284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and in vitro biological activity of new deaza analogues of folic acid, aminopterin, and methotrexate with an L-ornithine side chain.
    Rosowsky A; Forsch RA; Bader H; Freisheim JH
    J Med Chem; 1991 Apr; 34(4):1447-54. PubMed ID: 2016722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methotrexate analogues. 33. N delta-acyl-N alpha-(4-amino-4-deoxypteroyl)-L-ornithine derivatives: synthesis and in vitro antitumor activity.
    Rosowsky A; Bader H; Cucchi CA; Moran RG; Kohler W; Freisheim JH
    J Med Chem; 1988 Jul; 31(7):1332-7. PubMed ID: 3385730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and antifolate activity of 5-methyl-5,10-dideaza analogues of aminopterin and folic acid and an alternative synthesis of 5,10-dideazatetrahydrofolic acid, a potent inhibitor of glycinamide ribonucleotide formyltransferase.
    Piper JR; McCaleb GS; Montgomery JA; Kisliuk RL; Gaumont Y; Thorndike J; Sirotnak FM
    J Med Chem; 1988 Nov; 31(11):2164-9. PubMed ID: 3184124
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural features of 5,10-dideaza-5,6,7,8-tetrahydrofolate that determine inhibition of mammalian glycinamide ribonucleotide formyltransferase.
    Baldwin SW; Tse A; Gossett LS; Taylor EC; Rosowsky A; Shih C; Moran RG
    Biochemistry; 1991 Feb; 30(7):1997-2006. PubMed ID: 1993209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of 8-deazahomofolic acid and its tetrahydro derivative.
    DeGraw JI; Colwell WT; Brown VH; Sato M; Kisliuk RL; Gaumont Y; Thorndike J; Sirotnak FM
    J Med Chem; 1988 Jan; 31(1):150-3. PubMed ID: 3121855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical and biological studies on 2-desamino-2-methylaminopterin, an antifolate the polyglutamates of which are more potent than the monoglutamate against three key enzymes of folate metabolism.
    Rosowsky A; Galivan J; Beardsley GP; Bader H; O'Connor BM; Russello O; Moroson BA; DeYarman MT; Kerwar SS; Freisheim JH
    Cancer Res; 1992 Apr; 52(8):2148-55. PubMed ID: 1313737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methotrexate analogues. 26. Inhibition of dihydrofolate reductase and folylpolyglutamate synthetase activity and in vitro tumor cell growth by methotrexate and aminopterin analogues containing a basic amino acid side chain.
    Rosowsky A; Freisheim JH; Moran RG; Solan VC; Bader H; Wright JE; Radike-Smith M
    J Med Chem; 1986 May; 29(5):655-60. PubMed ID: 2871191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier- and receptor-mediated transport of folate antagonists targeting folate-dependent enzymes: correlates of molecular-structure and biological activity.
    Westerhof GR; Schornagel JH; Kathmann I; Jackman AL; Rosowsky A; Forsch RA; Hynes JB; Boyle FT; Peters GJ; Pinedo HM
    Mol Pharmacol; 1995 Sep; 48(3):459-71. PubMed ID: 7565626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Folate analogues. 31. Synthesis of the reduced derivatives of 11-deazahomofolic acid, 10-methyl-11-deazahomofolic acid, and their evaluation as inhibitors of glycinamide ribonucleotide formyltransferase.
    Nair MG; Murthy BR; Patil SD; Kisliuk RL; Thorndike J; Gaumont Y; Ferone R; Duch DS; Edelstein MP
    J Med Chem; 1989 Jun; 32(6):1277-83. PubMed ID: 2498518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tight binding of folate substrates and inhibitors to recombinant mouse glycinamide ribonucleotide formyltransferase.
    Sanghani SP; Moran RG
    Biochemistry; 1997 Aug; 36(34):10506-16. PubMed ID: 9265631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrate specificity of mammalian folylpolyglutamate synthetase for 5,10-dideazatetrahydrofolate analogs.
    Habeck LL; Mendelsohn LG; Shih C; Taylor EC; Colman PD; Gossett LS; Leitner TA; Schultz RM; Andis SL; Moran RG
    Mol Pharmacol; 1995 Aug; 48(2):326-33. PubMed ID: 7651366
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of 10-acetyl-5,8-dideazafolic acid: a potent inhibitor of glycinamide ribonucleotide transformylase.
    Caperelli CA; Conigliaro J
    J Med Chem; 1986 Oct; 29(10):2117-9. PubMed ID: 3761327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and biological evaluation of N alpha-(5-deaza-5,6,7,8-tetrahydropteroyl)-L-ornithine.
    Singh SK; Singer SC; Ferone R; Waters KA; Mullin RJ; Hynes JB
    J Med Chem; 1992 May; 35(11):2002-6. PubMed ID: 1375963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Folic acid-enhanced synergy for the combination of trimetrexate plus the glycinamide ribonucleotide formyltransferase inhibitor 4-[2-(2-amino-4-oxo-4,6,7,8-tetrahydro-3H-pyrimidino[5,4,6][1,4]thiazin -6-yl)-(S)-ethyl]-2,5-thienoylamino-L-glutamic acid (AG2034): comparison across sensitive and resistant human tumor cell lines.
    Faessel HM; Slocum HK; Rustum YM; Greco WR
    Biochem Pharmacol; 1999 Mar; 57(5):567-77. PubMed ID: 9952321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel pyrrolo[2,3-d]pyrimidine antifolate TNP-351: cytotoxic effect on methotrexate-resistant CCRF-CEM cells and inhibition of transformylases of de novo purine biosynthesis.
    Itoh F; Russello O; Akimoto H; Beardsley GP
    Cancer Chemother Pharmacol; 1994; 34(4):273-9. PubMed ID: 8033293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis and biological activity of an acyclic analogue of 5,6,7,8-tetrahydrofolic acid, N-[4-[[3-(2,4-diamino-1,6-dihydro-6-oxo-5- pyrimidinyl)propyl]amino]-benzoyl]-L-glutamic acid.
    Kelley JL; McLean EW; Cohn NK; Edelstein MP; Duch DS; Smith GK; Hanlon MH; Ferone R
    J Med Chem; 1990 Feb; 33(2):561-7. PubMed ID: 2299624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tetrahydrohomofolate polyglutamates as inhibitors of thymidylate synthase and glycinamide ribonucleotide formyltransferase in Lactobacillus casei.
    Thorndike J; Kisliuk RL; Gaumont Y; Piper JR; Nair MG
    Arch Biochem Biophys; 1990 Mar; 277(2):334-41. PubMed ID: 2106831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N10-substituted 5,8-dideazafolate inhibitors of glycinamide ribonucleotide transformylase.
    Caperelli CA
    J Med Chem; 1987 Jul; 30(7):1254-6. PubMed ID: 3599031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.